Join to View Full Profile
3 Cooper PlzRm 215Camden, NJ 08103
Phone+1 856-963-2439
Fax+1 856-338-9211
Dr. Lerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2003 - 2006
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2001 - 2003
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1998
Certifications & Licensure
NJ State Medical License 2006 - 2027
PA State Medical License 2001 - 2012
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
Publications & Presentations
PubMed
- Corrigendum to "PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S." [Oral Oncol. 161 (2025) 107146].Glenn J Hanna, Dandan Zheng, Wei Gao, Gleicy M Hair, Lei Ai
Oral Oncology. 2025-10-01 - 11 citationsPembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048...Makoto Tahara, Richard Greil, Danny Rischin, Kevin J Harrington, Barbara Burtness
European Journal of Cancer. 2025-05-15 - PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S.Glenn J Hanna, Dandan Zheng, Wei Gao, Gleicy M Hair, Lei Ai
Oral Oncology. 2025-02-01
Press Mentions
Cancer Immunotherapy Clinical Study Approved for Phase 1June 7th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
